Helping entrepreneurs build tomorrow’s most successful companies

London
Joined November 2012
Charting the path for drug +digital device combinations: Otsuka, Proteus resubmit FDA application | ow.ly/bnKn30bZU9k
Looking forward to officially launching @MolWarehouse Series A at @Health2eu BCN May 3 2017 #EC2VC 2017 #health2eu ow.ly/G61p30aCmV9
Nice example of device + app suite to cover the whole patient pathway in an indication ow.ly/9IUw305Vnqu
Help Molecular Warehouse reach the stretch target of £750K raised on Crowdcube! Capital At Risk. ow.ly/98I9305psT4
Inspiring! :: Why I Left the Practice of Medicine to Make Medicines | David Schenkein | Pulse | LinkedIn ow.ly/yLDU304PNsS
The first Brexited startup? " Carrick will be based in Dublin but have an R&D center in Oxford, UK" $95m investment ow.ly/Dky5304OH8f
Thanks to all our investors! @MolWarehouse looking forward to improving the lives of millions of patients ow.ly/4C2j304OjBd
Bringing diagnostics into the digital age! Molecular Warehouse raising £300,000 on Crowdcube. Capital At Risk. ow.ly/LdXn304zSR5
roundcape retweeted
Replying to @MolWarehouse
@MolWarehouse publishes its advanced second-generation bisensor technology in JACS ow.ly/Fxtd302V25q
3
1
As suspected, @theranos has no new technology, just a miniaturised ELISA assay platform with colorimetric readout - pscp.tv/w/1jMJgyPOBYlKL
Tech giants pushing further into healthcare: GSK and Alphabet strike electrifying tie-up — FT.com ow.ly/EWGT302OWtq
Biotech Roars Back On Forbes' List Of The Top Venture Capitalists - Forbes ow.ly/ZT4P3
UK Synthetic Biology Strategic Plan 2016 aims to achieve a £10bn UK synthetic biology market by 2030 ow.ly/YP6XK
UK Synthetic Biology Strategic Plan 2016 aims to achieve a £10bn UK synthetic biology market by 2030 ow.ly/YP6Xq